91 related articles for article (PubMed ID: 10851068)
1. IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation.
Reiss K; Wang JY; Romano G; Furnari FB; Cavenee WK; Morrione A; Tu X; Baserga R
Oncogene; 2000 May; 19(22):2687-94. PubMed ID: 10851068
[TBL] [Abstract][Full Text] [Related]
2. Expression of the type 1 insulin-like growth factor receptor is up-regulated in primary prostate cancer and commonly persists in metastatic disease.
Hellawell GO; Turner GD; Davies DR; Poulsom R; Brewster SF; Macaulay VM
Cancer Res; 2002 May; 62(10):2942-50. PubMed ID: 12019176
[TBL] [Abstract][Full Text] [Related]
3. AKT activation up-regulates insulin-like growth factor I receptor expression and promotes invasiveness of human pancreatic cancer cells.
Tanno S; Tanno S; Mitsuuchi Y; Altomare DA; Xiao GH; Testa JR
Cancer Res; 2001 Jan; 61(2):589-93. PubMed ID: 11212254
[TBL] [Abstract][Full Text] [Related]
4. PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells.
Zhao H; Dupont J; Yakar S; Karas M; LeRoith D
Oncogene; 2004 Jan; 23(3):786-94. PubMed ID: 14737113
[TBL] [Abstract][Full Text] [Related]
5. Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer.
Rochester MA; Riedemann J; Hellawell GO; Brewster SF; Macaulay VM
Cancer Gene Ther; 2005 Jan; 12(1):90-100. PubMed ID: 15499378
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of regulation of cell adhesion and motility by insulin receptor substrate-1 in prostate cancer cells.
Reiss K; Wang JY; Romano G; Tu X; Peruzzi F; Baserga R
Oncogene; 2001 Jan; 20(4):490-500. PubMed ID: 11313980
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT
Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells.
Byron SA; Horwitz KB; Richer JK; Lange CA; Zhang X; Yee D
Br J Cancer; 2006 Nov; 95(9):1220-8. PubMed ID: 17043687
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.
Guvakova MA; Surmacz E
Cancer Res; 1997 Jul; 57(13):2606-10. PubMed ID: 9205064
[TBL] [Abstract][Full Text] [Related]
10. PTEN gene therapy induces growth inhibition and increases efficacy of chemotherapy in prostate cancer.
Tanaka M; Rosser CJ; Grossman HB
Cancer Detect Prev; 2005; 29(2):170-4. PubMed ID: 15829377
[TBL] [Abstract][Full Text] [Related]
11. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
Jackson JG; Zhang X; Yoneda T; Yee D
Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
[TBL] [Abstract][Full Text] [Related]
12. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J
Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001
[TBL] [Abstract][Full Text] [Related]
13. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Id2 gene expression by the insulin-like growth factor I receptor requires signaling by phosphatidylinositol 3-kinase.
Belletti B; Prisco M; Morrione A; Valentinis B; Navarro M; Baserga R
J Biol Chem; 2001 Apr; 276(17):13867-74. PubMed ID: 11278691
[TBL] [Abstract][Full Text] [Related]
15. Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis.
Nussbaum T; Samarin J; Ehemann V; Bissinger M; Ryschich E; Khamidjanov A; Yu X; Gretz N; Schirmacher P; Breuhahn K
Hepatology; 2008 Jul; 48(1):146-56. PubMed ID: 18537183
[TBL] [Abstract][Full Text] [Related]
16. Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.
Surmacz E; Bartucci M
J Exp Clin Cancer Res; 2004 Sep; 23(3):385-94. PubMed ID: 15595626
[TBL] [Abstract][Full Text] [Related]
17. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
19. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
Goel HL; Breen M; Zhang J; Das I; Aznavoorian-Cheshire S; Greenberg NM; Elgavish A; Languino LR
Cancer Res; 2005 Aug; 65(15):6692-700. PubMed ID: 16061650
[TBL] [Abstract][Full Text] [Related]
20. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance.
Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR
Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]